These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37796423)
1. Focused panel sequencing points to genetic predisposition in non-cirrhotic intrahepatic portal hypertension patients in India. Aaron R; Premkumar K; Chapla A; Vijayalekshmi B; Zachariah U; Elias E; Kodiatte TA; Daniel D; Jude J; Balasubramanian KA; Nair SC; Thomas N; Ramakrishna B; Eapen CE; Goel A Indian J Gastroenterol; 2024 Apr; 43(2):434-442. PubMed ID: 37796423 [TBL] [Abstract][Full Text] [Related]
2. ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension. Goel A; Raghupathy V; Amirtharaj GJ; Chapla A; Venkatraman A; Ramakrishna B; Ramachandran A; Thomas N; Balasubramanian KA; Mackie I; Elias E; Eapen CE Indian J Gastroenterol; 2017 Sep; 36(5):380-389. PubMed ID: 28980147 [TBL] [Abstract][Full Text] [Related]
3. ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension. Goel A; Alagammai PL; Nair SC; Mackie I; Ramakrishna B; Muliyil J; Keshava SN; Eapen CE; Elias E Indian J Gastroenterol; 2014 Jul; 33(4):355-63. PubMed ID: 24756423 [TBL] [Abstract][Full Text] [Related]
4. Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency. Mackie I; Eapen CE; Neil D; Lawrie AS; Chitolie A; Shaw JC; Elias E Dig Dis Sci; 2011 Aug; 56(8):2456-65. PubMed ID: 21573942 [TBL] [Abstract][Full Text] [Related]
5. Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options. Goel A; Elias JE; Eapen CE; Ramakrishna B; Elias E J Clin Exp Hepatol; 2014 Sep; 4(3):247-56. PubMed ID: 25755567 [TBL] [Abstract][Full Text] [Related]
6. Arsenicosis, possibly from contaminated groundwater, associated with noncirrhotic intrahepatic portal hypertension. Goel A; Christudoss P; George R; Ramakrishna B; Amirtharaj GJ; Keshava SN; Ramachandran A; Balasubramanian KA; Mackie I; Fleming JJ; Elias E; Eapen CE Indian J Gastroenterol; 2016 May; 35(3):207-15. PubMed ID: 27225799 [TBL] [Abstract][Full Text] [Related]
7. Rare Variants in the ADAMTS13 Von Willebrand Factor-Binding Domain Contribute to Pediatric Stroke. Stoll M; Rühle F; Witten A; Barysenka A; Arning A; Strauss C; Nowak-Göttl U Circ Cardiovasc Genet; 2016 Aug; 9(4):357-67. PubMed ID: 27412500 [TBL] [Abstract][Full Text] [Related]
8. Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis. Pagliari MT; Cairo A; Boscarino M; Mancini I; Pappalardo E; Bucciarelli P; Martinelli I; Rosendaal FR; Peyvandi F PLoS One; 2021; 16(10):e0258675. PubMed ID: 34662354 [TBL] [Abstract][Full Text] [Related]
9. Altered von Willebrand Factor and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension. Islek A; Ilhan D; Ozturk N; Guven B; Sag E J Pediatr Hematol Oncol; 2021 Oct; 43(7):e951-e956. PubMed ID: 33369998 [TBL] [Abstract][Full Text] [Related]
10. Idiopathic non-cirrhotic intrahepatic portal hypertension: common cause of cryptogenic intrahepatic portal hypertension in a Southern Indian tertiary hospital. Madhu K; Avinash B; Ramakrishna B; Eapen CE; Shyamkumar NK; Zachariah U; Chandy G; Kurian G Indian J Gastroenterol; 2009; 28(3):83-7. PubMed ID: 19907954 [TBL] [Abstract][Full Text] [Related]
11. Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis. Goel A; Ramakrishna B; Muliyil J; Madhu K; Sajith KG; Zachariah U; Ramachandran J; Keshava SN; Selvakumar R; Chandy GM; Elias E; Eapen CE Dig Dis Sci; 2013 Jan; 58(1):179-87. PubMed ID: 22918688 [TBL] [Abstract][Full Text] [Related]
12. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Eapen CE; Nightingale P; Hubscher SG; Lane PJ; Plant T; Velissaris D; Elias E Dig Dis Sci; 2011 Jan; 56(1):227-35. PubMed ID: 20499175 [TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis. Lotta LA; Tuana G; Yu J; Martinelli I; Wang M; Yu F; Passamonti SM; Pappalardo E; Valsecchi C; Scherer SE; Hale W; Muzny DM; Randi G; Rosendaal FR; Gibbs RA; Peyvandi F J Thromb Haemost; 2013 Jul; 11(7):1228-39. PubMed ID: 23648131 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 haplotype on coronary artery disease. Lasom S; Komanasin N; Settasatian N; Settasatian C; Kukongviriyapan U; Intharapetch P; Senthong V Blood Coagul Fibrinolysis; 2017 Jun; 28(4):286-294. PubMed ID: 27536857 [TBL] [Abstract][Full Text] [Related]
15. What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors. Goel A; Ramakrishna B; Zachariah U; Sajith KG; Burad DK; Kodiatte TA; Keshava SN; Balasubramanian KA; Elias E; Eapen CE Indian J Med Res; 2019 Apr; 149(4):468-478. PubMed ID: 31411170 [TBL] [Abstract][Full Text] [Related]
16. Porto-pulmonary hypertension exacerbated by platelet transfusion in a patient with ADAMTS13 deficiency. Elias JE; Mackie I; Eapen CE; Chu P; Shaw JC; Elias E J Hepatol; 2013 Apr; 58(4):827-30. PubMed ID: 23149063 [TBL] [Abstract][Full Text] [Related]
18. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Bongers TN; de Maat MP; van Goor ML; Bhagwanbali V; van Vliet HH; Gómez García EB; Dippel DW; Leebeek FW Stroke; 2006 Nov; 37(11):2672-7. PubMed ID: 16990571 [TBL] [Abstract][Full Text] [Related]
19. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Bowen DJ; Collins PW Blood; 2004 Feb; 103(3):941-7. PubMed ID: 14525793 [TBL] [Abstract][Full Text] [Related]
20. The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension. Newnham M; South K; Bleda M; Auger WR; Barberà JA; Bogaard H; Bunclark K; Cannon JE; Delcroix M; Hadinnapola C; Howard LS; Jenkins D; Mayer E; Ng C; Rhodes CJ; Screaton N; Sheares K; Simpson MA; Southwood M; Su L; Taboada D; Traylor M; Trembath RC; Villar SS; Wilkins MR; Wharton J; Gräf S; Pepke-Zaba J; Laffan M; Lane DA; Morrell NW; Toshner M Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30655285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]